{"cluster": 48, "subcluster": 35, "abstract_summ": "This study aims to find a new antiviral combination regimen by investigating the frequency of clinically relevant and objectively identified comorbidities, and the clustering of these clinical syndromes and varying results of treatment with antiviral drugs in patients hospitalized with severe COVID-19.However, few studies reported the impacts of COVID\u201019 on liver function in patients with chronic liver diseases.We aimed to describe a case series of COVID\u201019 patients with chronic hepatitis B virus (HBV) infection.We report here the clinical characteristics and therapeutic procedure for four patients with mild or severe 2019-nCoV pneumonia admitted to Shanghai Public Health Clinical Center.According to the results, the inclusion of antiviral drugs in therapeutic regimens based on symptomatic treatment had no significant additional impact on the improvement in COVID\u201019 patients.", "title_summ": "A case series of COVID\u201019 patients with chronic hepatitis B virus infectionEffect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID\u201019 and Mycoplasma pneumoniae in the USAEvaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID\u201019) Pneumonia in Shanghai, ChinaClinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.", "title_abstract_phrases": "Evaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID\u201019) Pneumonia in Shanghai, ChinaThe aim of our study was to evaluate the therapeutic effect of antiviral drugs on COVID\u201019 pneumonia.This study aims to find a new antiviral combination regimen by investigating the frequency of clinically relevant and objectively identified comorbidities, and the clustering of these clinical syndromes and varying results of treatment with antiviral drugs in patients hospitalized with severe COVID-19.We aimed to describe a case series of COVID\u201019 patients with chronic hepatitis B virus (HBV) infection.We report here the clinical characteristics and therapeutic procedure for four patients with mild or severe 2019-nCoV pneumonia admitted to Shanghai Public Health Clinical Center.However, few studies reported the impacts of COVID\u201019 on liver function in patients with chronic liver diseases."}